Aemetis Q1 2026 Shows Operational Improvement but Balance Sheet Peril Persists

What happened

Aemetis reported Q1 2026 revenue of $54.6M, up 27% YoY, with gross profit of $2.8M versus a $5.1M loss last year, driven by RNG volume growth of 55% and a rebound in India Biodiesel. The company recognized $4.0M in Section 45Z tax credits, its first quarter of ongoing eligibility, and delivered initial equipment for the MVR and RNG station projects. However, despite these operational gains, the company still carries negative equity of ~$305M and ~$286.7M of debt due within 12 months, far exceeding its ~$95.7M market cap. The DeepValue Master Report maintains a STRONG SELL stance, citing explicit going-concern language, high-cost secured debt, and a history of losses. These improved Q1 metrics do not materially alter the precarious liquidity position, as the company remains dependent on refinancing and project execution to avoid distress.

Implication

The Q1 results show early signs of operational turnaround, but the overwhelming debt burden and negative equity mean bondholders effectively own the company. Investors should require a significant deleveraging event—such as a successful India IPO or comprehensive refinancing—before considering a position. Until then, the stock is a high-risk option on policy and execution with limited margin of safety.

Thesis delta

The prior STRONG SELL view was based on acute balance-sheet risk. Q1 2026 results show operational improvement but do not change the fundamental overhang of near-term debt maturities and going concern doubt. The risk of dilution or restructuring still dominates, so the bearish stance remains unchanged.